Page last updated: 2024-10-30

mefenamic acid and Cholera Infantum

mefenamic acid has been researched along with Cholera Infantum in 3 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"5 mg and 15 mg showed a similar profile in pain reduction and dysmenorrhea symptoms when compared with mefenamic acid."9.11Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. ( Baracat, EC; Barbosa, IC; Bedone, AJ; Camargos, A; Cortes, RJ; de Mello, NR; de Souza, RN; Martinez Alcala, FO; Rumi, DO; Tomaz, G; Velasco, JA, 2004)
"5 mg and 15 mg showed a similar profile in pain reduction and dysmenorrhea symptoms when compared with mefenamic acid."5.11Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. ( Baracat, EC; Barbosa, IC; Bedone, AJ; Camargos, A; Cortes, RJ; de Mello, NR; de Souza, RN; Martinez Alcala, FO; Rumi, DO; Tomaz, G; Velasco, JA, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, EC1
Shin, JY1
Kubota, K1
Man, KKC1
Park, BJ1
Pratt, N1
Roughead, EE1
Wong, ICK1
Kao Yang, YH1
Setoguchi, S1
de Mello, NR1
Baracat, EC1
Tomaz, G1
Bedone, AJ1
Camargos, A1
Barbosa, IC1
de Souza, RN1
Rumi, DO1
Martinez Alcala, FO1
Velasco, JA1
Cortes, RJ1
Johnson, RH1
Hornabrook, RW1
Lambie, DG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age[NCT02255045]Phase 2/Phase 368 participants (Actual)Interventional2014-06-27Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for mefenamic acid and Cholera Infantum

ArticleYear
Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
    Acta obstetricia et gynecologica Scandinavica, 2004, Volume: 83, Issue:7

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double

2004
Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
    Acta neurologica Scandinavica, 1986, Volume: 73, Issue:5

    Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Gastrointestinal Diseases; Humans; Male;

1986

Other Studies

1 other study available for mefenamic acid and Cholera Infantum

ArticleYear
Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: A multi-database, international cohort study.
    Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Australia; Celecoxib; Databases, F

2018